Drug Shortage Report for SANDOZ PROCTOMYXIN HC SUPPOSITORIES
Report ID | 124304 |
Drug Identification Number | 02242528 |
Brand name | SANDOZ PROCTOMYXIN HC SUPPOSITORIES |
Common or Proper name | SANDOZ PROCTOMYXIN HC SUPPOSITOIRES |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE |
Strength(s) | 5MG 10MG 5MG 10MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | 12SUP ST V1 CA |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-09-11 |
Estimated end date | 2020-10-16 |
Actual end date | 2020-10-16 |
Shortage status | Resolved |
Updated date | 2020-10-19 |
Company comments | |
Health Canada comments | |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.